Copiktra (Duvelisib)
- Medicine Name: Copiktra
- Generic Name: Duvelisib
- Dosage Form & Strength: Capsules: 25 mg, 15 mg
- Manufactured By: Secura Bio, Inc.
Copiktra is a kinase inhibitor used for the treatment of adult patients with:
- Relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) after at least a couple of prior therapies.
- Relapsed or refractory follicular lymphoma (FL) after at least a couple of prior systemic therapies.
Recommended Dosage: The recommended dose of Copiktra (duvelisib) is 25 mg administered as oral capsules twice daily (BID) with or without food. A cycle consists of 28 days. Swallow the capsules whole. Do not open, chew or break the capsules.
If a dose is skipped/missed by fewer than 6 hours, take the skipped/missed dose promptly and take the very next dose as usual. If a dose is missed by more than 6 hours, wait and take the very next dose at about the usual time.
- Grade 3/4 neutropenia may occur in patients receiving Copiktra (duvelisib) Capsules 25 mg. Monitor neutrophil counts at least every 2 weeks for the initial 2 months of therapy, and at least weekly in those with neutrophil counts < 1.0 Gi/L (Grade 3-4).
- Fatal/serious infections may occur in Duvelisib-treated patients. Monitor for signs and symptoms of infection. Withhold this treatment if infection is suspected.
- Fatal/serious cutaneous reactions may occur in patients treated with Duvelisib Capsules. Withhold this treatment.
- Fatal/serious pneumonitis may occur in those treated with Duvelisib. Monitor for pulmonary signs/symptoms and interstitial infiltrates. Withhold the therapy.
- Fatal/serious diarrhea or colitis may occur in patients treated with copiktra 15 mg capsule. Monitor for the establishment of colitis or severe diarrhea. Withhold this treatment.
- Duvelisib can cause fetal harm if administered to a pregnant woman. Females of reproductive age and males with female partners of reproductive age should use apt contraception throughout the treatment and for at least 30 days after the last dose.
- There is no data on the presence of duvelisib or its metabolites in human milk, the effects on the breastfed child. Due to the potential for serious side effects from duvelisib in a breastfed child, lactating women should not breastfeed while on therapy and for at least 30 days after the final dose.
What documents are required to import COPIKTRA to India?
COPIKTRA (Duvelisib) Capsule can be imported by patients or government hospitals on the name of the patients only.
The following documentation are required in order to import the medicinal product:
- Valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients Identity Proof (issued by government of India)
How does order be confirmed?
The order will be confirmed only after the receipt of:
- Valid prescription of Doctor
- Import permit if applicable
Is COPIKTRA available in India?
COPIKTRA (Duvelisib Capsule) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
COPIKTRA can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
IPN (Indian Pharma Network) can facilitate the supply of COPIKTRA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +91-9310090915| TOLL-FREE Number: 1800-889-1064 or write us at E-mail: info@indianpharmanetwork.in for Copiktra price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network is able to source COPIKTRA (Cancer Treatment Medicines) from across the globe, and has the ability to supply. Indian Pharma Network (IPN) offers its customers worldwide access to the best available treatment.
Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Copiktra®?
Duvelisib is Generic Name for the trade name drug Copiktra®.
What is the Manufacturer Name of Copiktra®?
Copiktra® is manufactured by Secura Bio, Inc.
Is Copiktra® approved by the FDA?
Yes, Copiktra® is approved by the FDA. Date of first/initial approval: September 24, 2018.
What is the dosage and form of Copiktra® supplied?
Copiktra® is supplied as Capsules: 15 mg, 25 mg for oral administration.
What are the most common side effects with Copiktra®?
The most common side effects with Copiktra® include: rash, fatigue, diarrhea or colitis, neutropenia, pyrexia, cough, upper respiratory infection, nausea, pneumonia, anemia and musculoskeletal pain.
Where can I get Copiktra® at the best price in India?
To get the best Copiktra price in India, you can connect with Indian Pharma Network, or any other WHO-GDP and ISO 9001:2008 authorized Pharmaceutical Wholesaler Company. A medical prescription is required while buying Copiktra Capsules.
How much does Copiktra® cost in India?
The Copiktra cost in India is very reasonable and can vary. In order to procure this medication authentically, you can Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Copiktra®?
Store at 20-25°C (68-77°F), with excursions permitted at 15-30°C (59-86°F). Dispense blister packs in the original container.
Is it safe to buy Copiktra® online from India?
Yes, You can buy Copiktra capsules online from India at the best price from Indian Pharma Network if Copiktra® has not been approved or is not available in your country.
What are the Highlights of prescribing information for Copiktra®?
Click Here to download full Copiktra prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.